Filing Details

Accession Number:
0000950170-23-057499
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-01 16:30:07
Reporting Period:
2023-10-30
Accepted Time:
2023-11-01 16:30:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1745999 Beam Therapeutics Inc. BEAM Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1963879 Amy Simon C/O Beam Therapeutics Inc.
238 Main Street
Cambridge MA 02142
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-10-30 3,448 $18.70 65,469 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.